These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25407217)

  • 1. Recent advances in proteomically subtyping pancreatic ductal adenocarcinomas and their potential clinical impact.
    Roesli C
    Expert Rev Proteomics; 2015 Feb; 12(1):5-8. PubMed ID: 25407217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
    Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
    J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead.
    Kim H; Park J; Wang JI; Kim Y
    Expert Rev Proteomics; 2017 Nov; 14(11):963-971. PubMed ID: 28926720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.
    Funel N; Giovannetti E; Pollina LE; del Chiaro M; Mosca F; Boggi U; Campani D
    Expert Rev Mol Diagn; 2011 Sep; 11(7):695-701. PubMed ID: 21902531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma.
    Kuhlmann L; Nadler WM; Kerner A; Hanke SA; Noll EM; Eisen C; Espinet E; Vogel V; Trumpp A; Sprick MR; Roesli CP
    Pancreas; 2017 Mar; 46(3):311-322. PubMed ID: 27846146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution.
    Hernández-Muñoz I; Skoudy A; Real FX; Navarro P
    Pancreatology; 2008; 8(4-5):462-9. PubMed ID: 18724072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
    Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers in pancreatic cancer diagnosis.
    Herreros-Villanueva M; Gironella M; Castells A; Bujanda L
    Clin Chim Acta; 2013 Mar; 418():22-9. PubMed ID: 23305796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
    Muckenhuber A; Berger AK; Schlitter AM; Steiger K; Konukiewitz B; Trumpp A; Eils R; Werner J; Friess H; Esposito I; Klöppel G; Ceyhan GO; Jesinghaus M; Denkert C; Bahra M; Stenzinger A; Sprick MR; Jäger D; Springfeld C; Weichert W
    Clin Cancer Res; 2018 Jan; 24(2):351-359. PubMed ID: 29101303
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
    Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
    J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations.
    Zhou W; Capello M; Fredolini C; Piemonti L; Liotta LA; Novelli F; Petricoin EF
    J Proteome Res; 2011 Apr; 10(4):1944-52. PubMed ID: 21309613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma.
    Igbinigie E; Guo F; Jiang SW; Kelley C; Li J
    Clin Chim Acta; 2019 Jan; 488():226-234. PubMed ID: 30452897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
    Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
    Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
    Winter JM; Yeo CJ; Brody JR
    J Surg Oncol; 2013 Jan; 107(1):15-22. PubMed ID: 22729569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers of early pancreatic cancer.
    Goggins M
    J Clin Oncol; 2005 Jul; 23(20):4524-31. PubMed ID: 16002843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.